loading page

PESI Score for Predicting Clinical Outcomes in Pulmonary Embolism Patients with Right Ventricular Involvement
  • +8
  • Sharon Shalom Natanzon,
  • Alexander Fardman,
  • Fernando Chernomordik,
  • Israel Mazin,
  • Romana Herscovici,
  • Orly Goitein,
  • Sagit Ben-Zekry,
  • Anan Younis,
  • Avishay Grupper,
  • Shlomi Matetzky,
  • Roy Beigel
Sharon Shalom Natanzon
Sheba Medical Center

Corresponding Author:[email protected]

Author Profile
Alexander Fardman
Sheba Medical Center
Author Profile
Fernando Chernomordik
Sheba Medical Center
Author Profile
Israel Mazin
Sheba Medical Center
Author Profile
Romana Herscovici
Sheba Medical Center
Author Profile
Orly Goitein
Sheba Medical Center
Author Profile
Sagit Ben-Zekry
Sheba Medical Center
Author Profile
Anan Younis
Sheba Medical Center
Author Profile
Avishay Grupper
Sheba Medical Center
Author Profile
Shlomi Matetzky
Sheba Medical Center
Author Profile
Roy Beigel
Sheba Medical Center
Author Profile

Abstract

Background: Pulmonary embolism (PE) patients with right ventricular (RV) involvement are a heterogenous group who mandate further risk stratification. Our objective was to evaluate the efficacy of the PE severity index (PESI) for predicting adverse clinical outcomes among PE patients with RV involvement. Methods and Results: Consecutive normotensive PE patients with RV involvement were allocated according to admission PESI score (PESI <4 vs. PESI ≥4). The primary outcome included hemodynamic instability and in-hospital mortality. Secondary outcomes included each component of the primary outcome as well as mechanical ventilation, thrombolytic therapy, acute kidney injury, and major bleeding. Multivariable logistic regression model was performed to assess the independent association between the PESI score and primary outcome. C-Statistic was used to compare the PESI with the BOVA score. A total of 253 patients were evaluated: 95 (38%) with a PESI of ≥4. Of them, 82 (32%) patients were classified as intermediate-low risk and 171 (68%) as intermediate-high risk. Fifty (20%) patients had at least 1 adverse event. Multivariate analysis demonstrated the PESI to be an independent predictor for the primary outcome (HR 4.81, CI 95%, 1.15-20.09, P=0.031), which was increased with a concomitant increase of the PESI score (PESI 1:4.2%, PESI 2: 3.4%, PESI 3:12%, PESI 4: 16.3%, PESI 5:23.1%, P for trend <0.001). C-Statistic analysis for the PESI score yielded an AUC-0.746 (0.637-0.854), P=0.001, compared to the BOVA score: AUC-0.679 (0.584-0.775), P=0.011. Conclusion: PESI score was found to predict adverse outcomes among normotensive PE patients with RV involvement.